GLATOPA Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Glatopa, and what generic alternatives are available?
Glatopa is a drug marketed by Sandoz and is included in two NDAs.
The generic ingredient in GLATOPA is glatiramer acetate. There are five drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the glatiramer acetate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Glatopa
A generic version of GLATOPA was approved as glatiramer acetate by MYLAN on October 3rd, 2017.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for GLATOPA?
- What are the global sales for GLATOPA?
- What is Average Wholesale Price for GLATOPA?
Summary for GLATOPA
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 26 |
| Clinical Trials: | 1 |
| Drug Prices: | Drug price information for GLATOPA |
| DailyMed Link: | GLATOPA at DailyMed |
Recent Clinical Trials for GLATOPA
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Kansas Medical Center | Phase 1 |
US Patents and Regulatory Information for GLATOPA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sandoz | GLATOPA | glatiramer acetate | INJECTABLE;SUBCUTANEOUS | 090218-001 | Apr 16, 2015 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Sandoz | GLATOPA | glatiramer acetate | INJECTABLE;SUBCUTANEOUS | 206921-001 | Feb 12, 2018 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
